國立虎尾科技大學 |

Human iPS cells in disease modelling

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Human iPS cells in disease modelling/ edited by Keiichi Fukuda.
其他作者:	Fukuda, Keiichi.
出版者:	Tokyo :Springer Japan : : 2016.,
面頁冊數:	vii, 99 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Stem cells. -
電子資源:	http://dx.doi.org/10.1007/978-4-431-55966-5
ISBN:	9784431559665

Human iPS cells in disease modelling
Human iPS cells in disease modelling[electronic resource] /edited by Keiichi Fukuda. - Tokyo :Springer Japan :2016. - vii, 99 p. :ill., digital ;24 cm.

Chapter 1 Recent Improvements and Emerging Issues in iPSC Generation for the Modeling of Disease -- Chapter 2 Cardiomyopathy -- Chapter 3 Modelling Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy with Patient-specific iPSCs -- Chapter 4 Cardiac Arrhythmia Modelling Using iPS Cells -- Chapter 5 iPSC Disease Modeling of Laminopathies -- Chapter 6 Hematological Disorders -- Chapter 7 Inherited Metabolic Disorders of the Liver.

Human iPS cells have a great potential to be cell sources for regenerative medicine because of the promise of infinite self-renewal and the capability to differentiate into multiple cell types. This book focuses on another great potential of human iPS cells, which is the establishment of human disease models using patient-specific iPS cells. Human iPS cells can be easily obtained from a patient's somatic cells and provide the entire information on the patient's genome. Accordingly, we can generate disease models for inheritable diseases in cell culture dishes using iPS cells. This is a quite new technique but holds tremendous potential for our increased understanding of pathogenesis, and will then be the basis for novel drug development industries. All the authors are leading researchers in this field and they have reported many kinds of patient-derived iPS cells. In this book, they introduce the aspects that could be recapitulated in terms of disease modelling as well as further innovative findings such as novel pathogenetic insights and novel therapies.

ISBN: 9784431559665

Standard No.: 10.1007/978-4-431-55966-5doiSubjects--Topical Terms:

679759
Stem cells.

LC Class. No.: QH588.S83

Dewey Class. No.: 616.02774

Human iPS cells in disease modelling
LDR:02476nam a2200325 a 4500 001 862850
003 DE-He213
005 20160909110254.0
006 m d
007 cr nn 008maaau
008 170720s2016 ja s 0 eng d
020 $a 9784431559665 $q (electronic bk.)
020 $a 9784431559641 $q (paper)
024 7 $a 10.1007/978-4-431-55966-5 $2 doi
035 $a 978-4-431-55966-5
040 $a GP $c GP
041 0 $a eng
050 4 $a QH588.S83
072 7 $a PSAK $2 bicssc
072 7 $a SCI017000 $2 bisacsh
072 7 $a SCI049000 $2 bisacsh
082 0 4 $a 616.02774 $2 23
090 $a QH588.S83 $b H918 2016
245 0 0 $a Human iPS cells in disease modelling $h [electronic resource] / $c edited by Keiichi Fukuda.
260 $a Tokyo : $c 2016. $b Springer Japan : $b Imprint: Springer,
300 $a vii, 99 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1 Recent Improvements and Emerging Issues in iPSC Generation for the Modeling of Disease -- Chapter 2 Cardiomyopathy -- Chapter 3 Modelling Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy with Patient-specific iPSCs -- Chapter 4 Cardiac Arrhythmia Modelling Using iPS Cells -- Chapter 5 iPSC Disease Modeling of Laminopathies -- Chapter 6 Hematological Disorders -- Chapter 7 Inherited Metabolic Disorders of the Liver.
520 $a Human iPS cells have a great potential to be cell sources for regenerative medicine because of the promise of infinite self-renewal and the capability to differentiate into multiple cell types. This book focuses on another great potential of human iPS cells, which is the establishment of human disease models using patient-specific iPS cells. Human iPS cells can be easily obtained from a patient's somatic cells and provide the entire information on the patient's genome. Accordingly, we can generate disease models for inheritable diseases in cell culture dishes using iPS cells. This is a quite new technique but holds tremendous potential for our increased understanding of pathogenesis, and will then be the basis for novel drug development industries. All the authors are leading researchers in this field and they have reported many kinds of patient-derived iPS cells. In this book, they introduce the aspects that could be recapitulated in terms of disease modelling as well as further innovative findings such as novel pathogenetic insights and novel therapies.
650 0 $a Stem cells. $3 679759
650 0 $a Cell culture. $3 583545
650 1 4 $a Life Sciences. $3 593888
650 2 4 $a Stem Cells. $3 782732
650 2 4 $a Cell Culture. $3 783886
700 1 $a Fukuda, Keiichi. $3 997278
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-4-431-55966-5
950 $a Biomedical and Life Sciences (Springer-11642)